Foundation of the Company in the 60s :
In the early 1960s, Japan was suffering from the outbreak of poliomyelitis. At the time, one of the few available cures for poliomyelitis was the live vaccines, which was produced in the former USSR. However, at the height of the Cold War between the Western and Eastern Blocs, the Japanese government was reluctant to approve the introduction of the medicines from the Soviet Union. Mothers, whose children were suffering from poliomyelitis, were quick to act. They soon gathered from throughout the nation, and made petitions to the Japanese authority to approve the live vaccine from the Soviet Union, with supports from various organizations, media and scholars. Iskra Industry actively organized and coordinated the mass movement.
Being faced with rising demand from the society, the Japanese authority finally gave approved the introduction of the Soviet live vaccine. Iskra Industry obtained the permission to import vaccine from the Soviet Union, and to distribute them within Japan. It is estimated that more than 20 million children in Japan were saved from the threat of poliomyelitis.The first 5 years of the history of Iskra Industry was marked by the trade of various medicines from the Soviet Union. However, in the mid-60s Iskra Industry began exporting petrochemical products to the USSR, and importing chemical materials, such as white phosphorus and chromic compounds. At the end of the 60s Iskra also began importing medical devices to the Soviet Union. The dealings of the medical devices quickly became the core of the trade with the Soviet Union.
Growth of the Company in the 70s:
In the 1970s the dealing between Iskra Industry and the Soviet Union consisted 30% of the whole Russo-Japanese trade during the time. Iskra’s trade of the chemical products consisted 90%, and the trade of the medical devices consisted 98% of the whole dealings between Japan and the Soviet Union.